Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (12987)	8/19/1998 5:30:00 PM
From: RockyBalboa	Respond to of 18691

Really awkward, this story. No wonder that most of us put the co. on the "red" portfolio. There is only one problem: They could sell the vaccine patent to one of the big players, like Schering (this is less likely), raking in a lot of new cash. Touting such plans could raise the price a bit, as Zonagen's announcements usually stir up some price action, like the 10 of Aug, when the Q results were published, with a small jump to 19 3/4. So, also the houston article may easily be exploited by the company, making the stock more unpredictable and perhaps causing people to reduce short positions. Christian Are there actual figures: burn rate, amount of stocks-to-be issued, preferred stock which are not reflected in the 2Q?